March 14, 2017Journal of the American Society of Echocardiography
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
Key result
Echocardiography, augmented by advanced modalities and artificial intelligence, serves as an essential and accurate tool for the early detection, evaluation, and management of congenital heart defects.
Figures
PICO
P
Population
Congenital heart defects (CHD)
E
Exposure / Comparator
Echocardiography (2D, 3D, fetal, stress, TEE, and AI-assisted)
Limitations
- High operator dependence requiring specialized training and expertise
- Suboptimal imaging quality in patients with poor acoustic windows, obesity, or prior thoracic surgeries
- Spatial resolution constraints compared to cardiac MRI and CT
- High cost and limited accessibility of advanced 3D and AI technologies in resource-limited environments
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“With many new advances over the last decade in diagnosis and treatment of valvular regurgitation, there was a clear need to update the original ASE guidelines from 2003. While echocardiography with Doppler is the first-line diagnostic modality to help clinicians in formulating an accurate diagnosis on the causes and severity of the regurgitant valves, an integrative approach of clinical and imaging parameters is strongly recommended to enhance accuracy. These updated guidelines aim first to educate clinicians on how to evaluate these complex lesions, and second, to provide recommendations on assessing the severity of the valvular insufficiency; there is a worldwide need for both, as valvular regurgitation is the most difficult valve lesion to assess.”
Abstract
No abstract yet. The journal hasn't published one we can show.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Zoghbi et al. (2017) conducted a review in Congenital heart defects (CHD). Echocardiography (2D, 3D, fetal, stress, TEE, and AI-assisted) was evaluated. Echocardiography, augmented by advanced modalities and artificial intelligence, serves as an essential and accurate tool for the early detection, evaluation, and management of congenital heart defects.